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Low doses (0.143 pg/ml per 1cP cells) of the lipopolysaccharide toxin (LPS) from Sulmonellu typhimurium were shown 
to increase (after an 18 h incubation) the intracellular content of free cholesterol (CH), esterified cholesterol (EC) and 
triglycerides (TG) by 3040% in the primary culture of rabbit hepatocytes. A similar increase was found for the incorpora- 
tion of r4C]acetate into these lipids. The concentration of lipids in cultural medium, under these conditions, was also 
augmented: by 30-40s for CH; by 5&60% for TG and by 6&80% for EC. Higher doses (up to 50 ,ug/ml) of LPS hardly 
affected the lipid content in hepatocytes but strongly (by two-fold) inhibited the secretion of lipids. It is suggested that 
in vivo low concentrations of LPS in bloodstream (in the absence of conspicuous pathology) might induce hyperlipidemia 
directly influencing on hepatic cells, while, under the higher concentrations of LPS, hyperlipidemia caused by cachectin 
(or tumor necrosis factor) is probably observed. 
Lipopolysaccharide toxin; Hyperlipidemia; (Rabbit hepatocyte) 
1. INTRODUCTION 
Infection of mammals with Gram-negative 
bacteria or their lipopolysaccharide toxins (LPS) 
leads to a noticeable increase in the lipid content in 
blood plasma, the amount of P-migrating very low 
density lipoproteins being augmented above all 
[1,2]. Though the biological grounds for such 
hyperlipidemia are not presently cleared up, many 
investigators assume that it does not arise as a 
direct consequence of the LPS appearance in 
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plasma but rather is due to the action of cachectin 
(or TNF), a protein which is secreted by 
macrophages in large quantities in response to LPS 
[3]. Thus, this protein can increase several-fold the 
level of TG in plasma of rats which is found to en- 
sue from the stimulation of the biosynthesis and 
secretion of TG by the liver cells [4,5]. Since the at- 
tention of researchers has been basically focused 
on studying the TNF effects, the direct influence of 
LPS on the production and secretion of lipids by 
hepatocytes remains still underinvestigated. It is 
well known that, on the one hand, liver is the cen- 
tral organ governing the lipid metabolism, but, on 
the other hand, it greatly contributes to the 
elimination of various harmful substances from 
the blood. Despite the fact that in the bloodstream 
LPS is primarily being attacked by 
monocytes/macrophages 161, the pronounced 
quantities of toxin are capable of binding to 
hepatocytes [7,8]. Application of the primary 
culture of hepatocytes permits one to elucidate the 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/89/$3.50 0 1989 Federation of European Biochemical Societies 155 
Volume 256, number 1,2 FEBS LETTERS October 1989 
direct effects of LPS on the liver cells ruling out 
the influence of other factors, e.g. TNF. 
Here, we report the ability of low concentrations 
of LPS to enhance in the primary culture of rabbit 
hepatocytes both the accumulation of lipids in the 
cell and their secretion into the outer medium. 
2. MATERIALS AND METHODS 
Lipopolysaccharide toxin B of Salmonella typhimurium was 
supplied by Difco Laboratories (USA). All lipid standards were 
purchased from Sigma Chemical Co. (USA). Minimal essential 
medium with Earle’s salts, heat-inactivated fetal calf serum, 
kanamycin, L-glutamine, trypsin-EDTA, trypan blue and 
35-mm culture dishes were the products of Flow Laboratories 
(USA). Collagenase type IV (125-200 U/mg) was supplied by 
Sigma Chemical Co. Dispase II (0.5 Wmg) was purchased 
from Boehringer (FRG). [I-“C]Acetic acid, sodium salt (spec. 
act. 59 Ci/mol) was supplied by Amersham Corporation (UK). 
HPTLC plates, Silica Gel 60 (Merck, FRG) were used for lipid 
analyses. Solvents for HPLC were products of Burdick (USA). 
The primary culture of rabbit hepatocytes was prepared and 
maintained as described in detail elsewhere [9]. Before any ex- 
periments were started, hepatocytes were cultured for 36 h 
under standard conditions [9]. Throughout all the experiments 
more than 85% of cells excluded trypan blue dye, i.e. remained 
intact. For each experimental point, approx. 8 x lo5 cells were 
taken. LPS was administered into the cultural medium as an 
aqueous dispersion at final concentration of 0.1-50.0 pg/ml 
medium per lo6 cells. For determination of the de novo lipid 
biosynthesis, [14C]acetate (5 &i/ml) was added into the 
medium. Incubation in all cases lasted for 18 h. Then lipids 
were extracted and analyzed by HPTLC as reported earlier [9]. 
Briefly, PL were separated in a methyl acetate/n- 
propanol/chloroform/methanol/0.25% KC1 (25 : 25 : 28 : 10: 7, 
v/v) system [lo]; for measuring NL, a hexane/diethyl 
ether/acetic acid (15 : 2: 0.1, v/v) system was employed. Ap- 
plication of lipid samples on the HPTLC plate was performed 
with a special device, Linomat III (Camag, Switzerland), allow- 
ing the administration of an exact volume of solution ( f 0.1 ~1) 
on the narrow band (< 1 mm). PL were also analyzed by HPLC 
using a DuPont chromatograph with an analytical Zorbax-SIL 
(5 pm, 250 x 4.6 mm) column and following the procedure 
described in [1 11. Radioactivity was measured with a liquid scin- 
tillation counter. Concentrations of PL were determined by 
phosphorus analysis [12]. Concentrations of NL (and PL) were 
measured by quantitative densitometry [13] using an HPTLC 
scanner (Camag) connected with a registrating integrator 
SP-4100 (Spectra Physics, FRG). Protein was determined ac- 
cording to the method of Lowry [14]. Student’s t-test was 
employed for statistical estimates. 
3. RESULTS AND DISCUSSION 
Data of table 1 demonstrate that incubation of 
hepatocytes with low concentrations 
(0.10-0.25 pg/ml per lo6 cells) of LPS produces a 
significant increase (by 30-40’70) in the level of all 
major cellular NL, practically no differences bet- 
ween EC, CH and TG being observed. Incorpora- 
tion of [14C]acetate label characterizing the de 
novo lipid biosynthesis hows an analogous rise for 
these cellular NL. When the LPS concentration in 
the medium amounts to lo-50,ug/ml, the in- 
tracellular content of CH, EH and TG returns to 
normal. 
Similar, but less expressed, changes are found 
for hepatocyte PL (table 2). Namely, the in- 
tracellular concentrations of sphingomyelin, 
phosphatidylcholine and phosphatidylethanolam- 
ine, under the action of low doses of LPS, aug- 
ment by -2O%, while the level of minor negatively 
charged components (phosphatidylserine, 
phosphatidylinositol and ‘phosphatidic acid + car- 
Table 1 
Content of major neutral lipids and incorporation of [14C]acetate into NL in rabbit hepatocytes after an 18 h 
incubation with LPS 
LPS bg/ml 
per lo6 cells) 
PR 
CH 
cpm x lo-’ 
TG 
cpm x lo-’ Pg 
EC 
cpm x lo-’ 
0 29.7 k 3.1 151 * 17 45.3 * 5.1 511 + 48 47.5 + 5.3 13.1 + 1.4 
0.10 42.5 + 5.4” 222 + 34” 61.6 + 7.1a 807 k 97b 66.5 + 7.4a 20.7 + 3.0b 
0.25 40.7 f 6.1a 237 f 41a 57.2 + 5.0a 726 + 85b 61.8 f 7.7a 18.8 i 2.8= 
2.0 34.7 + 4.1 183 f 22 52.5 + 6.3 583 * 65 57.2 + 6.5 17.7 f 2.0a 
10.0 31.5 * 3.9 143 f 18 47.1 f 5.5 491 + 62 54.4 + 6.0 14.5 + 2.1 
50.0 32.1 + 3.5 147 * 21 46.8 & 5.3 519 + 57 55.6 + 6.2 15.2 + 2.2 
a 6 p 0.05 
b p < 0.01 
All data are given per 1 mg of cellular protein. Presented mean values + SD for 4-5 experiments 
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Table 2 
Content of phospholipids in rabbit hepatocytes after an 18 h incubation with LPS 
LPS 
&g/ml per 
lo6 cells) 
0 16.8 + 1.1 60.5 + 3.8 8.5 + 0.7 11.8 + 1.1 7.3 + 0.6 37.5 * 3.1 
0.10 20.0 k 1.6b 70.6 k 5.7b 12.1 + l.lC 17.1 * 2.0s 9.2 + 0.7b 44.8 + 4.0b 
0.25 21.1 + l.gb 68.6 f 6.1 11.7 * 1.2b 17.2 f 1.6’ 9.5 k l.Ob 46.6 f 4.9b 
2.0 17.8 f 1.7 64.2 + 6.7 7.9 + 0.8 12.9 + 1.5 8.7 + 0.9 39.5 + 5.0 
10.0 15.4 + 1.5 56.2 + 5.0 7.4 * 0.7 12.2 * 1.3 7.9 + 0.7 34.2 k 4.1 
PL 
SM” be) PC w psa bg) pIa f#g) PA+CLa &) PEa kg) 
’ SM, sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PI, phosphatidylinositol; PA, 
phosphatidic acid; CL, cardiolipin; PE, phosphatidylethanolamine 
b p < 0.05 
c p < 0.01 
All data are given per 1 mg of cellular protein. Presented mean values f SD for 3-4 experiments 
diolipin’ fraction) increases by 30-40%. At higher 
doses of LPS, the intracellular content of all PL 
falls down to control of even lower values. Incor- 
poration of [14C]acetate into cellular PL ex- 
periences the same, as for NL, alterations 
depending on the LPS dose in the outer medium 
(data not shown). This fact evidences that an in- 
crease in the content of PL in the cell is caused by 
their enhanced de novo biosynthesis. 
Further investigation has shown that LPS is 
capable not only of inducing the accumulation of 
lipids in the cell but also of stimulating their secre- 
tion into cultural medium. As one can see from 
table 3, low doses of LPS (0.10-0.25 pg/ml) 
markedly increase the amount of NL detected in 
the medium, i.e. the content of CH, TG and EC 
rises by 30-40%, 50-60% and 60-80%, respec- 
tively. The very high concentration of LPS 
(50 lug/ml) strongly reduces (by two-fold) the level 
of NL in the cultural medium. Since, at such a dose 
of toxin, the NL content in the cell keeps close to 
normal, we suppose that it is the lipid secretion 
that is inhibited by LPS (via suppressing the 
biosynthesis either of apolipoproteins or NL 
themselves). It is noteworthy that, in the present 
work, we have measured the concentrations of NL 
and PL in cells and medium only after an 18 h in- 
cubation with LPS. Though the amount of lipids 
being secreted in the primary culture of 
hepatocytes during this period is known to grow 
monotonously [ 151, one cannot exclude the 
possibility that that kinetics might be changed in 
the presence of LPS. 
Obviously, the increase in intracellular content 
of lipids (attributable to their de novo synthesis) 
requires the activation of the appropriate enzyme 
systems. LPS can reportedly elicit in hepatocytes 
various effects. Thus, interacting with the plasma 
membrane of the cell, toxin partly destabilizes its 
organization and alters a microviscosity of the 
lipid bilayer [8]; it can also perturb the hormone- 
receptor binding, stimulate the activity of en- 
dogenous phospholipase AZ and aspartate- 
transaminase; it affects the activity of cytochrome 
P-450, the synthesis of albumin and numerous pro- 
teins appearing in the acute phase of the disease 
([16,17] and references cited therein). Moreover, 
some authors have shown that under the endotoxic 
Table 3 
Content of major neutral lipids in medium of the primary 
culture of rabbit hepatocytes after an 18 h incubation with LPS 
LPS &g/ml CH” TGa EC” 
per IO6 cells) t&g) kg) t&g) 
0 2.8 * 0.3 16.8 + 1.8 4.1 + 0.5 
0.10 3.7 * 0.4b 25.5 zk 3.6b 6.7 + 0.8b 
0.25 3.8 k 0.5b 24.7 k 3.3b 7.0 + 0.9b 
2.0 3.3 * 0.4 21.8 k 2.9 5.9 + 0.7b 
10.0 2.5 + 0.3 17.1 k 2.5 5.1 + 0.6 
50.0 1.3 * 0.3b 7.3 zk 1.4c 2.9 + 0.4b 
a Similar changes were found for ‘%Z-biosynthetically abeled 
lipid 
b p < 0.05 
c p d 0.01 
Data are given per 1 mg of cellular protein. Presented mean 
values + SD for 3-4 experiments 
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shock caused by LPS, the biosynthesis of many 
eicosanoids becomes different [ 181. We suggest 
that one of the first events triggering such an ‘ac- 
tivation’ of hepatocytes might be the LPS- 
inducible hydrolysis of polyphosphoinositides 
resulting in the formation of second messengers: 
inositol phosphates and diacylglycerols. This effect 
of LPS was already ascertained for other cells, e.g. 
macrophages [6], B-lymphocytes [ 191 and blood 
platelets [20]. 
Considering hyperlipidemia observed in vivo in 
the course of LPS infection, one can hypothesize 
that in the acute period of the disease (at high con- 
centrations of LPS) this phenomenon is likely due 
to cachectin (or TNF) [3] secreted in this case in 
large amounts. However, in the absence of con- 
spicuous pathology (i.e. at low concentrations of 
LPS) when macrophages release negligible quan- 
tities of cachectin, hyperlipidemia attributable to 
the direct action of LPS on the liver cells might oc- 
cur. Certainly, the magnitude of the effect produc- 
ed by LPS itself greatly yields to that of cachectin 
(TNF) [4,5], but, keeping in mind the probably 
prolonged periods for which low doses of toxin are 
capable of exerting their influence on hepatic cells, 
it seems reasonable to propose that it may have 
far-reaching consequences. 
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